Singular Genomics Systems, Inc. Stock price
Equities
OMIC
US82933R1005
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5142 USD | -0.50% | +4.36% | +11.76% |
Mar. 20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
Mar. 18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
Financials (USD)
Sales 2024 * | 3.65M | Sales 2025 * | 18.93M | Capitalization | 38.01M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -82M | EV / Sales 2024 * | 4.08 x |
Net cash position 2024 * | 23.1M | Net Debt 2025 * | 23.43M | EV / Sales 2025 * | 3.25 x |
P/E ratio 2024 * |
-0.42
x | P/E ratio 2025 * |
-0.47
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.87% |
Latest transcript on Singular Genomics Systems, Inc.
1 day | -0.50% | ||
1 week | +4.36% | ||
Current month | -9.79% | ||
1 month | -12.37% | ||
3 months | +9.17% | ||
6 months | +35.32% | ||
Current year | +11.76% |
Managers | Title | Age | Since |
---|---|---|---|
Eli Glezer
FOU | Founder | 55 | 16-05-31 |
Andrew Spaventa
CEO | Chief Executive Officer | 39 | 16-05-31 |
Dalen Meeter
DFI | Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Barker
FOU | Founder | 82 | 16-08-31 |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-04-30 |
Michael Pellini
BRD | Director/Board Member | 58 | 17-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 8 M€ | +9.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.5142 | -0.50% | 57,356 |
24-03-27 | 0.5168 | +1.12% | 110,408 |
24-03-26 | 0.5111 | +1.21% | 72,998 |
24-03-25 | 0.505 | -1.94% | 87,377 |
24-03-22 | 0.515 | +4.53% | 70,222 |
Delayed Quote Nasdaq, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.76% | 38.01M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |